Sero-epidemiology of mumps in western Europe.

Seroprevalence of IgG Antibodies against Mumps in Bulgarian Children under 18 Years of Age.

OBJECTIVE The objective of this study was to determine the prevalence of IgG antibodies against mumps in a representative stratified sample of children under 18 years of age in Pleven district, Bulgaria. STUDY DESIGN Cross sectional study. MATERIALS AND METHODS A cross-sectional, sero-epidemiologic survey of 132 children aged under 18 years was conducted in Pleven district. They were distri...

Mumps outbreak in Israel's highly vaccinated society: are two doses enough?

Mumps outbreaks in recent years have given rise to questions about the effectiveness of the mumps vaccine. This study examined the epidemiological data from a recent mumps outbreak in Israel and from outbreaks in other countries with high vaccination coverage, and considered whether long-established vaccination policies designed to protect against mumps are in need of revision. Of over 5000 cas...

[Evolution of measles, rubella and mumps from the third seroepidemiological survey in the autonomous region of Madrid, Spain].

In this study results against measles, rubella and mumps obtained in the III Sero-epidemiological Survey of the Autonomous Region of Madrid, performed in 1999-2000, were related to the posterior evolution of these diseases in this Region. The prevalence of antibodies against measles, rubella and mumps was >90%, >95% and <90 %, respectively. Despite of the good results obtained for rubella and m...

Satisfactory Measles, Mumps, Rubella and Varicella Seroprevalence in Adult Refugees in Western Europe – But Don ́t Forget the Kids

Varicella vaccination in Europe – taking the practical approach

Varicella is a common viral disease affecting almost the entire birth cohort. Although usually self-limiting, some cases of varicella can be serious, with 2 to 6% of cases attending a general practice resulting in complications. The hospitalisation rate for varicella in Europe ranges from 1.3 to 4.5 per 100,000 population/year and up to 10.1% of hospitalised patients report permanent or possibl...